Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruyi Zhenbao Pills for poststroke thalamic pain
ChiCTR2400080969Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ruyizhenbao pill in Thalamic pain syndrome (TPS) and central poststroke pain (CPSP), sponsored by Beijing University of Chinese Medicine. Primary endpoints: Short-Form McGill Pain Questionnaire score and Dosage of painkillers used. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
ruyizhenbao pill
03
Conditions
Thalamic pain syndrome (TPS)central poststroke pain (CPSP)
Beyond the preview
Go deeper on ChiCTR2400080969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080969.